Granuloma-forming interstitial pneumonia induced by nivolumab: a possible immune-related adverse event of the lung

Nivolumab, a monoclonal antibody targeting the PD-1, has recently been used as a standard treatment for lung cancer, melanoma and renal cell carcinoma. We herein report the case of a patient undergoing treatment for non-small cell lung cancer (NSCLC) who developed interstitial pneumonia which featur...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int Cancer Conf J
Päätekijät: Kashiwada, Takeru, Saito, Yoshinobu, Minegishi, Yuji, Kokuho, Nariaki, Takahashi, Akihiko, Takahashi, Satoshi, Atsumi, Kenichiro, Seike, Masahiro, Azuma, Arata, Kubota, Kaoru, Terasaki, Yasuhiro, Gemma, Akihiko
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Japan 2017
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498337/
https://ncbi.nlm.nih.gov/pubmed/31149487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-017-0291-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia